Systemic Lupus Erythematosus in Children: Clinical and Laboratory Aspects of Diagnosis and Course
View Article


systemic lupus erythematosus
autoimmune disease
immunological markers

How to Cite

Z. A., S., D. T., A., N. Ya., F., & A. A., R. (2024). Systemic Lupus Erythematosus in Children: Clinical and Laboratory Aspects of Diagnosis and Course. Excellencia: International Multi-Disciplinary Journal of Education (2994-9521), 2(7), 68-75.


Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology characterized by the hyperproduction of organ-nonspecific autoantibodies to various components of the cell nucleus, leading to immune-inflammatory damage to tissues and internal organs. Research aim: to study the role of immunological markers in the pathogenesis of SLE development in children. Materials and methods: data collection was conducted between 2022-2024 at the Tashkent Pediatric Medical Institute clinic. Preliminary studies show that the imbalance of immunological markers and the increase in autoantibodies are associated with the severity and recurrent nature of the disease.

View Article


Kostik M.M. , Snegireva L.S. , Dubko M.F. , etc. How to recognize a patient with autoinflammatory syndrome: Clinical and diagnostic algorithms // Modern rheumatology. – 2013. – No. 3. – P. 14–20.

Kostik M.M. , Kuchinskaya E.M. , Abduragimova F.N. and others. Experience with the use of rituximab in children with systemic lupus erythematosus: a retrospective study of a series of cases // Issues of modern pediatrics. – 2016. – T. 15. – No. 3. – P. 295–300.

Kuchinskaya E.M. , Kostik M.M. , Chasnyk V.G. Modern foundations of a formalized description of the course of systemic lupus erythematosus in children // Pediatrician. – 2017. – T. 8. – No. 2. – P. 68–80.

Arici ZS, Batu ED, Ozen S. Reviewing the Recommendations for Lupus in Children. Curr Rheumatol Rep.2015;17:17-30. doi:10.1007/s11926-014-0489-5.

Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and pediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771-1782. doi: 10.1136/annrheumdis-2012-201940.

Brunner HI, Gladman DD, Ibañez D, et al. Difference in disease features between childhood-onset and adultonset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556-562. doi: 10.1002/art.23204.

Group KDIGOKGW. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. 2012;2:139-274.

Mok CC. Treat-to-target in systemic lupus erythematosus: are we there yet? Expert Rev Clin Pharmacol. 2016;9(5):675-680. doi: 10.1586/ 17512433.2016.1146589.

Mosca M, Bombardieri S. Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol. 2006;24(6):99-104.

Van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis. 2014;73(6):958-967. doi: 10.1136/annrheumdis-2013-205139.

Van Vollenhoven RF, Voskuyl A, Morand E. Remission in SLE: closing in on the target. Ann Rheum Dis. 2015;74:2103-2106. doi: 10.1136/annrheum-dis-2015-208231.